Recap: Mersana Therapeutics Q3 Earnings

Mersana Therapeutics (NASDAQ:MRSN) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Mersana Therapeutics posted an EPS of $-0.61.

Mersana Therapeutics (NASDAQ:MRSN) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Mersana Therapeutics posted an EPS of $-0.61.

Revenue was up $5.56 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 33.33% increase in the share price the next day.

 

To track all earnings releases for Mersana Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Allakos Q1 Earnings

Allakos (NASDAQ:ALLK) reported its Q1 earnings results on Friday, May 6, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Allakos missed estimated earnings by 84.62%, reporting an EPS of $-3.6 versus an estimate of $-1.95.

ALLK

Read More

Recap: AppHarvest Q2 Earnings

AppHarvest (NASDAQ:APPH) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings AppHarvest beat estimated earnings by 3.45%, reporting an EPS of $-0.28 versus an estimate of $-0.29.

APPH

Read More

Earnings Outlook For A10 Networks

A10 Networks (NYSE:ATEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-01. Here's what investors need to know before the announcement. Analysts estimate that A10 Networks will likely report an Earnings Per Share (EPS) of $0.17.

ATEN